会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 51. 发明申请
    • METHOD AND COMPOSITION FOR FREE LIGAND ASSAYS
    • 免费配对测定的方法和组合
    • WO1983003306A1
    • 1983-09-29
    • PCT/GB1983000078
    • 1983-03-17
    • EKINS, Roger, Philip
    • G01N33/54
    • G01N33/544G01N33/53G01N33/78
    • A method for determining the amount of free ligand in a test sample where the ligand is also present bound to one or more endogenous receptors, comprising combining the test sample, ligand receptor and unlabelled, differential binding ligand analogue, incubating to permit the free ligand and unlabelled, differential binding ligand analogue to compete for the ligand receptor separating the ligand analogue, determining the amount of ligand receptor bound to the ligand or to the ligand analogue, and correlating the amount of bound ligand receptor to the amount of free ligand present in the test sample.
    • 用于测定测试样品中还存在配体的游离配体的量的方法与一种或多种内源性受体结合,包括组合测试样品,配体受体和未标记的差异结合配体类似物,孵育以允许游离配体和 未标记的差异结合配体类似物以竞争分配配体类似物的配体受体,确定与配体或配体类似物结合的配体受体的量,并将结合的配体受体的量与存在于配体中的游离配体的量相关联 测试样品。
    • 53. 发明申请
    • MEASUREMENT OF ANALYTE CONCENTRATION
    • 分析浓度的测量
    • WO1984001031A1
    • 1984-03-15
    • PCT/GB1983000210
    • 1983-08-26
    • EKINS, Roger, Philip
    • G01N33/54
    • G01N33/54306G01N33/74
    • The concentration of an analyte, such as a hormone or other biologically active material, in a fluid, especially a body fluid, is measured by contacting the fluid with a trace amount of a binding agent, such as an antibody, specific for the analyte, determining a figure representative of the proportional occupancy of binding sites on the binding agent and estimating from that figure the analyte concentration. Provided that the amount of binding agent is sufficiently small that its introduction has no significant effect on the total free analyte concentration, the proportional occupancy of binding sites is independent of the volume of the fluid and hence it is not necessary to measure accurately beforehand the volume of the fluid or fluid sample being tested. It is therefore possible to design a concentration-measuring device for insertion into a body fluid of a living creature for in situ measurement of concentration.
    • 流体,特别是体液中的分析物例如激素或其他生物活性物质的浓度通过使流体与痕量的分析物特异的结合剂如抗体接触来测量, 确定表示结合剂上结合位点的比例占有率的图,并从该图估计分析物浓度。 如果粘合剂的量足够小,使其引入对总的游离分析物浓度没有显着影响,则结合位置的比例占据与流体的体积无关,因此不需要预先准确地测量体积 的待测流体或流体样品。 因此,可以设计用于插入活体的体液中的浓度测定装置,以进行现场浓度测定。